On September 20th, 2017 Dr. Lindsay Sausville presented a paper entitled “Research and development spending to bring a single cancer drug to market and revenues after approval”.  We had a great discussion about immunotherapies and how they are marketed by pharmaceutical companies, and what payment structures might apply to these types of very expensive therapies.